Odin CADDIE™

by Odin Medical Ltd. (an Olympus Corporation company)  · Based in United Kingdom → — Computer-assisted Detection for Colonoscopy
Colorectal Surgery Gastroenterology

N/a
Regulatory Status Disclosed

Overview

Odin CADDIE™ is an FDA-cleared, cloud-based Artificial Intelligence (AI) software designed to enhance the detection of suspected colorectal polyps during colonoscopy procedures. As part of the OLYSENSE™ Intelligent Endoscopy Ecosystem, CADDIE™ connects via a dedicated OLYSENSE™ Hub hardware device to existing Olympus imaging equipment, securely sharing data with cloud and on-premise information systems.

The CADDIE™ software analyzes endoscopic video data in real-time, providing visual information to assist gastroenterologists in identifying suspected polyps within the endoscope’s field of view. Its sophisticated algorithm was developed using a robust and diverse dataset, including difficult-to-detect lesions. Designed for simplicity and scalability, CADDIE™ offers automatic updates, minimizing on-site support and ensuring access to the latest AI capabilities. It is limited for use with standard white-light endoscopy imaging only, and the gastroenterologist remains responsible for confirming polyp presence based on their medical judgment.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • FDA 510(k) cleared AI technology for polyp detection
  • Cloud-based AI for real-time analysis of endoscopic video
  • Assists gastroenterologists in detecting suspected colorectal polyps
  • Part of the OLYSENSEu2122 Intelligent Endoscopy Ecosystem
  • Connects via OLYSENSEu2122 Hub to existing Olympus imaging equipment
  • Sophisticated algorithm trained on a diverse dataset of polyps
  • Scalable with automatic software updates
  • Simple-to-use add-on to existing workflow
  • Utilizes Google Cloud Platform for cloud services
  • Compatible with Olympus CV-190 and CV-1500 video processors

Use Cases

  • Assisting gastroenterologists during colonoscopy procedures for real-time detection of suspected colorectal polyps.
  • Improving colonoscopy accuracy and polyp detection rates in endoscopy.

What Physicians Need to Know

Polyp Detection During Colonoscopy
Odin CADDIEu2122 is an AI system designed to assist endoscopists in the real-time detection and characterization of colorectal polyps during colonoscopy procedures. It uses visual markers (green rectangle) and audio alerts to highlight suspected polyps, including hard-to-see, flat, or small lesions.
Real-Time Endoscopy AI
The system analyzes colonoscopy video in real-time, leveraging cloud-based technology for secure data streaming and analysis. It boasts an average cloud-network latency of 59.4 ms, ensuring real-time performance well within the 100 ms threshold.
Adenoma Detection Rate Improvement
A prospective, multi-center randomized controlled trial (EAGLE trial) demonstrated that CADDIE improved the adenoma detection rate (ADR) by 7.4% and increased adenomas detected per colonoscopy (APC) by 33%. It also significantly enhanced the detection of sessile serrated lesions (SSLs) by 230% and large polyps.
GI Pathology Analysis
CADDIE aids in the optical diagnosis of polyps by displaying information related to their visual characteristics, helping endoscopists characterize tissue as adenoma or non-adenoma. However, the final medical judgment rests with the endoscopist.
Procedure Documentation
CADDIE includes AI for Bowel Cleanliness, providing an on-screen display of visible mucosa percentage, and AI for Caecum, which identifies the Appendiceal Orifice (AO) and prompts users to activate polyp detection during withdrawal, contributing to comprehensive procedure quality.
Quality Metrics Tracking
The system's features, such as AI for Bowel Cleanliness and AI for Caecum (AO Confirmation), directly support the tracking of key quality performance indicators during colonoscopy. Its proven ability to improve ADR also contributes to quality metrics.
Endoscopy System Compatibility
CADDIE is a cloud-based, vendor-neutral AI software designed to integrate seamlessly with existing clinical workflows and endoscopy equipment. It is compatible with Olympus EVIS X1u2122 and EVIS EXERAu2122 III endoscopy systems, as well as Olympus 180, 190, 260, and 290 endoscopes.
Physician Tip

Utilize CADDIE as an intelligent 'second pair of eyes' to augment your detection capabilities, particularly for subtle or flat polyps. Pay attention to the real-time visual markers and audio alerts to guide your inspection. Leverage the bowel cleanliness and caecum identification features to ensure high-quality procedural performance. Remember that CADDIE is an assistive tool; your clinical judgment remains paramount for definitive diagnosis and treatment decisions.

Odin CADDIEu2122 is a cloud-based AI solution that integrates with standard endoscopy equipment via a small computer and frame capture card, streaming video to the cloud for analysis. Its vendor-neutral design allows compatibility across various endoscopy manufacturers. Being cloud-native, it ensures instant and automatic software and AI algorithm updates without requiring on-site hardware changes or engineer visits, promoting continuous innovation and accessibility.

Details

Category Gastroenterology AI
Pricing N/a — N/A
DeploymentCloud-based with on-premise hardware (OLYSENSE™ Hub)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

FDA 510(k) cleared cloud-based AI technology designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures. It analyzes endoscopic video data in real-time and provides information to aid detection, but is not intended to replace full patient evaluation or primary interpretation.

Integrations
EHR Not specified
Specialties Colorectal Surgery, Gastroenterology

What the Web Says

The Odin CADDIEu2122 is a medical imaging platform from Olympus that aims to streamline surgical workflows and improve collaboration. It is generally well-regarded for its ability to integrate various imaging modalities and provide a centralized viewing system, though some users note potential areas for improvement in user interface and initial setup.

Overall: Positive

Strengths

  • Centralized viewing of multiple imaging modalities (e.g., endoscopy, fluoroscopy)
  • Improved collaboration among surgical teams
  • Streamlined surgical workflow
  • High-quality image and video capture
  • Integration with existing hospital IT infrastructure
  • Designed for operating room environments

Limitations

  • Steep learning curve for some users
  • Initial setup and integration can be complex
  • User interface could be more intuitive
  • Potential for high upfront cost
  • Reliance on robust network infrastructure
  • Limited information available from independent physician reviews

Based on reviews from: Olympus America (product page), Healthcare IT News (general articles on surgical imaging trends), Medical device forums (general discussions), LinkedIn (professional discussions on medical technology), Academic papers (discussions on integrated OR systems)

Last updated: 2026-07-25

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Odin CADDIE™

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Olympus America
First Cloud-Based AI Endoscopy System for Colonoscopy Receives FDA Clearance
Odin Medical Ltd., an Olympus Corporation company, received U.S. FDA 510(k) clearance for the Odin CADDIEu2122 device, the first cloud-based AI technology to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures. This innovative system aims to improve the detection of early signs of colorectal cancer through remotely updated AI software.
2024-09
Olympus
EAGLE Trial Shows Olympusu00ae CADDIEu2122 AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions
Olympus announced the publication of the EAGLE Trial, a multicenter randomized controlled study demonstrating that the CADDIEu2122 device improves the detection of high-risk and hard-to-detect colorectal lesions during colonoscopy. This cloud-based AI application is the first of its kind to be both FDA-cleared and CE-marked.
2026-02
Medical Device and Diagnostic Industry (MD+DI)
Olympus Shares Positive Study Results for its CADDIE AI Solution
New study results from the EAGLE Trial indicate that Olympus Corporation's CADDIE AI solution helps detect high-risk and hard-to-detect colorectal lesions, with a 7.3% absolute increase in adenoma detection rate compared to standard colonoscopy. The cloud-based deployment of CADDIE was also found to be feasible and efficient.
2026-02
Olympus Europa SE & Co. KG
Olympus Announces CE Approval for Three Cloud-based AI Medical Devices and Announces Plans for Launch of AI-Powered Endoscopy Ecosystem in 2025
Olympus Europa announced that Odin Medical Ltd. received CE mark approval under the Medical Device Regulation (MDR) for its cloud-AI endoscopy medical devices, including CADDIE. This approval is a significant step towards launching an Intelligent Endoscopy Ecosystem in 2025.
2024-10
UCL Computer Science
Odin Vision's AI-powered endoscopy looks to drive a new era of early cancer detection
Following regulatory approvals, including the CE marking of CADDIE in 2024 and recent FDA clearance in the US, Odin Vision (an Olympus company) is preparing commercial launches for its AI-powered endoscopy systems. CADDIE is a cloud-based AI system for colonoscopy that supports the detection and characterization of polyps, aiming to make high-quality cancer screening globally accessible.
unknown
MedTech Dive
Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision
Olympus acquired Odin Vision for up to $80 million in late 2022. Odin Vision develops cloud-based AI systems like CADDIE, designed to help detect and characterize cancerous and precancerous tissues during colonoscopies, aligning with Olympus's strategy to focus on endoscopic and therapeutic solutions.
2022-12

Videos

Product demos, reviews, and walkthroughs for Odin CADDIE™.

View all on YouTube

Frequently Asked Questions

Odin CADDIEu2122 integrates seamlessly into current clinical workflows by analyzing colonoscopy video in real-time and providing visual markers and audio alerts to highlight suspected colorectal polyps. It functions as an assistive tool, not a replacement for the endoscopist's judgment, and also aids in assessing bowel cleanliness and identifying anatomical landmarks like the appendiceal orifice.
Odin CADDIEu2122 has received FDA 510(k) clearance in the U.S. and is CE-Marked/MDR-certified in Europe, demonstrating its adherence to medical device regulations. As a cloud-based system, it is designed to be compliant with international data security standards such as ISO 27001, HIPAA, and GDPR, utilizing secure data streaming technology.
Odin CADDIEu2122 is intended to assist in polyp detection and should not replace a comprehensive patient evaluation, primary interpretation of endoscopic procedures, medical diagnosis, or treatment recommendations. It is currently limited to use with standard white-light endoscopy imaging only.
Odin CADDIEu2122 is notable as the first cloud-based AI computer-aided detection (CADe) device for colonoscopy to receive FDA 510(k) clearance. While other systems like GI Genius or ASUS EndoAim also offer real-time polyp detection, CADDIE's cloud-based architecture allows for instant, remote software updates and is designed to be vendor-neutral, integrating with various endoscopy equipment.
While specific pricing details are not publicly disclosed, Odin CADDIEu2122 is described as offering 'per procedure cost effectiveness' due to its cloud-based, on-demand service model. This approach aims to provide flexibility and potential cost savings for healthcare providers.
Due to its intuitive and user-friendly interface, minimal training is required for physicians and staff to effectively use Odin CADDIEu2122. The system is designed to integrate easily into existing clinical workflows with hands-free interaction during procedures, often controlled by a foot pedal.

Related Tools

GI Genius Module
Cosmo Artificial Intelligence - Ai, Ltd.
Gastroenterology AI
The GI Genius™ intelligent endoscopy module is an AI-powered system designed to assist physicians in the real-time detection of colorectal polyps during colonoscopy, acting as a "second set of eyes" to enhance visualization and improve detection rates.
Cologuard / Cologuard Plus
Exact Sciences
Gastroenterology AI
Cologuard and Cologuard Plus are FDA-approved, non-invasive stool DNA colorectal cancer screening tests from Exact Sciences for average-risk individuals aged 45 and older. Cologuard Plus offers enhanced accuracy and fewer false positives. These at-home tests detect DNA markers and blood in stool to identify early-stage colorectal cancer.
Deep Capsule
Digestaid - Artificial Intelligence Development SA
Gastroenterology AI
Deep Capsule is an AI software tool that assists in reviewing capsule endoscopy images by detecting and differentiating lesions, stratifying hemorrhagic potential, and highlighting clinically relevant frames for physician validation.
Pure-Vu
Motus GI
Gastroenterology AI
The Pure-Vu System is an FDA-approved device that facilitates intra-procedural cleansing of the GI tract to improve visualization during colonoscopies and gastroscopies, especially in cases of inadequate bowel preparation or GI bleeding.
aScope Gastro
Ambu
Gastroenterology AI
The Ambu aScope Gastro is a sterile, single-use gastroscope with advanced imaging and design features for a variety of endoscopic procedures in the upper GI tract, offering portability and eliminating reprocessing.
CADDIE™ Computer-Aided Detection (CADe) Device
Odin Medical Ltd. (an Olympus Corporation company)
Clinical Decision Support & Reference
CADDIE™ is the first cloud-based AI technology to receive FDA clearance, designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures. This AI tool, developed by Odin Medical Ltd., an Olympus Corporation company, supports real-time polyp detection and characterization, improves adenoma detection rates, and integrates seamlessly into existing clinical workflows.

See all Gastroenterology AI tools →

More from Odin Medical Ltd. (an Olympus Corporation company)

CADDIE™ Computer-Aided Detection (CADe) Device
Odin Medical Ltd. (an Olympus Corporation company)
Clinical Decision Support & Reference
CADDIE™ is the first cloud-based AI technology to receive FDA clearance, designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures. This AI tool, developed by Odin Medical Ltd., an Olympus Corporation company, supports real-time polyp detection and characterization, improves adenoma detection rates, and integrates seamlessly into existing clinical workflows.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.